MustGrow Study Reveals 96.1% Disease Control Of Clubroot Via Greenhouse Tests With TerraMG

MustGrow Biologics (CSE: MGRO) this morning released results from its successful greenhouse soil test results from testing its mustard-derived biopesticide tech on clubroot spores. The results have confirmed that the formulation is capable of disease control for clubroot resting spores within soils with an efficacy of 96.1% at an application rate of 0.5 gallons per acre.

A series of tests were conducted in regards to different application rates to determine the efficacy of the product. The study found that up to 98.5% disease control was possible at an application rate of 10 gallons per acre, however, the results of 96.1% disease control at 0.5 gallons per acre is much more significant from an economic feasibility standpoint. A total of five different application rates ranging from 0.5 gal/acre to 10 gal/acre proved disease control within the study.

The study was conducted by Discovery Seed Labs Ltd, a third party testing facility. Testing involved planting occurring seven days after soil treatment, with the roots then assessed seven weeks after planting.

“It is great to see that TerraMG continued to perform in the latest round of tests. With this new data we now plan on continuing the Clubroot work to the final field testing stage to potentially provide a valuable crop-protection tool for farmers. I am very hopeful that we can potentially have a key piece of the package to help growers manage this disease.”

Colin Bletsky, COO of MustGrow Biologics

Clubroot disease is a rapidly spreading pathogen that causes swelling or galls to form on the root of canola plants which can lead to premature death of the plant. No economical control measures currently exist for the disease, which is estimated to devastate approximately $500 million worth of canola crops annually.

MustGrow is currently planting to advance to larger scale field tests for the efficacy of its mustard-derived technology against clubroot disease in 2021.

MustGrow Biologics last traded at $0.44 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Arizona Metals: The Disappointing Kay Mine Resource Estimate

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

MustGrow: Organic Disease Control – The Daily Dive

Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow...

Monday, August 30, 2021, 01:30:00 PM

MustGrow: Seasoned Social Impact Financier Barry Palte Appointed To Advisory Board

MustGrow Biologics (CSE: MGRO) this morning announced that it has strengthened its advisory team. The...

Thursday, September 17, 2020, 08:38:56 AM

MustGrow Begins Testing On Clubroot Disease For Canola Crops

MustGrow Biologics Corp (CSE: MGRO) is looking to potentially expand the effective diseases in which...

Tuesday, February 25, 2020, 08:35:13 AM

MustGrow Announces 100% Control of Clubroot Disease With TerraMG

MustGrow Biologics Corp (CSE: MGRO) this morning announced test results for use of its patented...

Wednesday, May 27, 2020, 08:43:22 AM

MustGrow Announces 100% Control Of Root Rot Disease With Patented Biopesticide

MustGrow Biologics (CSE: MGRO) has seen further success with its mustard-derived biopesticide, this morning announcing...

Wednesday, January 20, 2021, 07:58:22 AM